Bioxytran, Inc.
BIXT
$0.077
-$0.0068-8.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 102.62% | -168.78% | -25.55% | 39.37% | -18.04% |
| Total Depreciation and Amortization | 31.58% | -34.48% | 93.33% | 0.00% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | 2,391.20% | -16.67% | -- |
| Total Other Non-Cash Items | -131.89% | 589.01% | -425.86% | -21.50% | -85.24% |
| Change in Net Operating Assets | -58.41% | 282.95% | -73.88% | -28.54% | 30,937.50% |
| Cash from Operations | 51.76% | -479.37% | 46.03% | 142.96% | 35.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -32.97% | -1,400.00% | 111.67% |
| Cash from Investing | -- | 100.00% | -32.97% | -1,400.00% | 111.67% |
| Total Debt Issued | -43.18% | 370.73% | -- | -100.00% | -89.85% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.18% | 370.73% | -- | -100.00% | -26.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.00% | 97.29% | -239.15% | 505.71% | 121.74% |